Sleep apnea is a common sleep disorder characterized by repeated interruptions in breathing during sleep, leading to fragmented sleep and potential health consequences.
Ranked by community outcomes, then evidence grade, Health Voice mentions, and recency.
Why it may help Sleep Apnea: Deficiency common in OSA
Vitamin D, a steroid hormone, is crucial for bone health and immune regulation, with growing evidence suggesting its involvement in thyroid disorders and other autoimmune conditions.
Why it may help Sleep Apnea: Supports circadian rhythm
N-Acetyl Cysteine (NAC) is a glutathione precursor with antioxidant, anti-inflammatory, and mucolytic properties, investigated for its potential therapeutic roles in a range of health conditions.
Magnesium citrate is a highly bioavailable form of magnesium often used to relieve constipation and support overall magnesium levels for various bodily functions.
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system. Supplemental GABA is commonly used to promote calmness and reduce acute anxiety.
Why it may help Sleep Apnea: Reduces inflammation contributing to OSA
Traditional calming herb studied for anxiety and sleep.
Why it may help Sleep Apnea: Regular exercise can improve muscle tone in the upper airway and reduce obesity, both of which are established factors that contribute to the severity of sleep apnea by preventing airway collapse.
Why it may help Sleep Apnea: Improves sleep quality
Why it may help Sleep Apnea: Eases sleep onset
Why it may help Sleep Apnea: Improves obesity-related OSA
Why it may help Sleep Apnea: Improves sleep quality
A calming mint-family herb that has been studied for hyperthyroidism, anxiety, and sleep.
Omega-3 fatty acids are essential polyunsaturated fats, primarily EPA and DHA, that may influence inflammatory and immune pathways, with ongoing research into their potential health applications.
Magnesium is an essential mineral vital for numerous bodily functions, including energy production, muscle and nerve function, and bone health.
Algal oil is a plant-based source of omega-3 fatty acids (EPA and DHA) that supports brain, eye, and heart health, offering a sustainable alternative to fish oil.
A daisy-like flower that has been studied for mild sedative and digestive effects.
Community outcomes
Self-reported by community members · not medical advice.
Self-reported community outcomes. Not medical advice. Requires at least three reports per remedy to surface.
Community outcome data is still being collected for this ailment.
Be the first to share your experience →As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.
Structured experience reports from people managing this condition. Not medical advice.
You can share without an account — we'll send a one-time code to verify your email. Or sign in.
Loading posts…
Community Discussions
How global health authorities view Sleep Apnea.
The Mayo Clinic emphasizes lifestyle changes like weight loss and avoiding alcohol. The American Academy of Sleep Medicine (AASM) provides clinical practice guidelines focusing on CPAP as the primary treatment for OSA. While some complementary therapies are explored for general sleep improvement, major bodies like the NIH and Cochrane generally do not endorse specific natural remedies as primary treatments for sleep apnea itself, often noting a lack of robust evidence for direct impact on apnea events. They typically recommend conventional medical evaluation and treatment.
Approved mentions from health educators, physicians, and researchers across podcasts, videos, and articles. Educational context only — does not influence the scientific evidence rating above.
Dr. Marie-Pierre St-Onge discusses the intricate relationship between nutrition and sleep, highlighting how even moderate sleep loss can impact appetite, hormones, and lead to weight gain. The conversation explores how specific foods, meal timing, and dietary patterns influence sleep quality, metabolic health, and weight management. Key takeaways include the importance of informed food choices and certain diets for supporting both sleep and cardiometabolic well-being.
"Even moderate sleep loss increases appetite, changes hunger-related hormones, and causes weight gain, even when calories are not increased. • Meal timing and specific foods affect sleep onset, sleep quality, and metabolism. • Specific foods and diets directly support weight loss, better sleep, and long-term cardiometabolic health."
Dr. Marie-Pierre St-Onge discusses the significant impact of sleep loss on appetite, hunger hormones, and weight gain, even without increased caloric intake. She highlights how specific foods, meal timing, and dietary patterns can influence sleep quality, metabolic health, and weight management. The conversation explores various dietary approaches and individual food items that support better sleep and long-term cardiometabolic well-being.
"Even moderate sleep loss increases appetite, changes hunger-related hormones, and causes weight gain, even when calories are not increased. • Meal timing and specific foods affect sleep onset, sleep quality, and metabolism. • Specific foods and diets directly support weight loss, better sleep, and long-term cardiometabolic health."
Indexed studies for Sleep Apnea, grouped by source type and quality.
Filter by source type
Pooled analyses across multiple human trials.
Diagnosis and Management of Resistant Hypertension: A Review.
Azizi M, Vongpatanasin W, Fisher NDL, Mahfoud F, Amar L, Kirtane AJ · JAMA · 2026 · n=331
Hypertension, defined as office systolic blood pressure (SBP) 130 mm Hg or greater and/or diastolic blood pressure 80 mm Hg or greater, affects 43.9% of women and 49.5% of men in the US. Approximately 19.7% of patients treated for hypertension have apparent resistant hypertension (blood pressure ≥130/80 mm Hg) despite using 3 or more antihypertensive medications, preferably a renin-angiotensin system blocker, a calcium channel blocker, and a thiazide-type diuretic, at maximally tolerated doses. Approximately 10% of patients treated for hypertension have true resistant hypertension confirmed with home or 24-hour ambulatory blood pressure monitoring to exclude white-coat hypertension (approximately 37.5% of apparent resistant hypertension) and after excluding medication nonadherence (approximately 50%) and secondary hypertension such as primary aldosteronism (approximately 5%-25%). Conditions associated with resistant hypertension include obesity, diabetes, chronic kidney disease
Yaldo L, Ngo A, Yaldo M, Abdelaal A, Ong J, Kiryakoza L · American journal of ophthalmology · 2026 · n=314
We evaluated whether obstructive sleep apnea (OSA) is associated with an increased risk of age-related macular degeneration (AMD). The population included adults with and without OSA. Outcomes included overall AMD risk and AMD stage-specific outcomes, including neovascular AMD (nAMD), non-neovascular AMD, late AMD with geographic atrophy (GA), and anti-VEGF therapy requirement. AMD is a leading cause of irreversible vision loss worldwide. OSA, characterized by intermittent hypoxia, oxidative stress, and vascular dysregulation, shares key pathogenic mechanisms with AMD. Understanding whether OSA increases AMD risk could help identify high-risk populations for earlier detection, monitoring, and intervention. We conducted a systematic review and meta-analysis of observational studies. PubMed, Web of Science, and Scopus were searched to June 27, 2025, supplemented by Google Scholar and citation tracking. Eligible studies reported AMD outcomes in both OSA and non-OSA groups. Methodologica
Castellanos MFI, da Costa JL, Oliveira LM, de Oliveira J, Zanatta FB, Callegaro CC · Sleep medicine · 2026
Obstructive sleep apnea (OSA) is a prevalent condition associated with an increased risk of multiple adverse health outcomes. CPAP is the standard treatment. However, poor adherence has increased interest in alternative and combined non-invasive therapies. This network meta-analysis compares the effectiveness of CPAP alone, isolated non-invasive therapies, and their combinations in key clinical outcomes for OSA. Fifty-five randomized controlled trials were analyzed, comparing interventions such as CPAP, mandibular advancement devices (MAD), oropharyngeal myofunctional therapy (OMT), inspiratory muscle training (IMT), and combined approaches. Outcomes assessed included apnea-hypopnea index (AHI), minimum oxygen saturation (SpO2), Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), and oxygen desaturation index (ODI). The certainty of evidence was evaluated using the GRADE framework. CPAP was the most effective for reducing AHI and improving minimum SpO2. OMT outper
Structured reviews of the full body of evidence (incl. Cochrane).
Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence.
Barros D, García-Río F · Sleep · 2019
Lipid metabolism deregulation constitutes the pathogenic basis for the development of atherosclerosis and justifies a high incidence of cardiovascular-related morbidity and mortality. Some data suggest that dyslipidemia may be associated with sleep-disordered breathing, mainly obstructive sleep apnea (OSA), due to alterations in fundamental biochemical processes, such as intermittent hypoxia (IH). The aim of this systematic review was to identify and critically evaluate the current evidence supporting the existence of a possible relationship between OSA and alterations in lipid metabolism. Much evidence shows that, during the fasting state, OSA and IH increase lipid delivery from the adipose tissue to the liver through an up-regulation of the sterol regulatory element-binding protein-1 and stearoyl-CoA desaturase-1, increasing the synthesis of cholesterol esters and triglycerides. In the postprandial state, lipoprotein clearance is delayed due to lower lipoprotein lipase activity, prob
Recommendations from medical societies (NICE, AHA, ADA, ACG, Endocrine Society…).
Continuous positive airway pressure for obstructive sleep apnoea in adults
National Institute for Health and Care Excellence (NICE)
This guideline evaluates the clinical and cost-effectiveness of continuous positive airway pressure (CPAP) for treating obstructive sleep apnoea in adults.
National Institute for Health and Care Excellence (NICE)
This guideline covers diagnosing and managing obstructive sleep apnoea and obstructive sleep apnoea hypopnoea syndrome in adults. It aims to improve recognition and treatment to reduce associated health risks.
Controlled human studies with random assignment.
Giblin K, Kaplan LM, Somers VK, Le Roux CW, Hunter DJ, Wu Q · Diabetes, obesity & metabolism · 2026 · n=5800
Retatrutide, a novel synthetic molecule, is a triple agonist activating the glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1 and glucagon receptors. The TRIUMPH clinical development program evaluates its safety and efficacy concurrently for the treatment of obesity and two related complications-obstructive sleep apnea (OSA) and knee osteoarthritis (OA). A novel basket trial design simultaneously evaluates retatrutide treatment across these multiple adiposity-related disease states. TRIUMPH consists of four Phase 3, multicenter, randomized, double-blind studies assessing weekly subcutaneous retatrutide compared to placebo, in conjunction with healthy diet and physical activity in over 5800 participants. The four trials consist of two weight management basket trials (TRIUMPH-1 and TRIUMPH-2) with OSA and/or OA protocols nested within the weight management trial; one weight management trial in a population with CVD (TRIUMPH-3); and one stand-alone OA trial (TRIUMPH-4
Healthy lifestyle factors and recurrent cardiovascular events in patients with OSA: the SAVE study.
You S, Zheng D, Loffler KA, McEvoy RD, Li Q, Luo Y · BMC medicine · 2025
The extent to which healthy lifestyle factors influence recurrent cardiovascular events in obstructive sleep apnea (OSA) patients is uncertain. To evaluate the association between adherence to baseline healthy lifestyle and the risk of recurrent cardiovascular events in OSA patients. Post hoc analyses of the Sleep Apnea Cardiovascular Endpoints (SAVE) study involving participants with moderate-to-severe OSA and established cardiovascular disease (CVD) who were randomized to continuous positive airway pressure (CPAP) plus usual care or usual care alone. We assigned a score ranging from 0 to 4 for each participant, based on the number of criteria met for the baseline health lifestyle factors of non-smoking, moderate-to-vigorous physical activity, ideal waist/hip ratio, and low-to-moderate alcohol consumption. In total, 2659 OSA patients with established CVD were included. The adjusted hazard ratios for participants with ≥ 2 healthy lifestyle factors compared with n
Malhotra A, Bednarik J, Chakladar S, Dunn JP, Weaver T, Grunstein R · Contemporary clinical trials · 2024 · n=469
Weight reduction is a standard recommendation for obstructive sleep apnea (OSA) treatment in people with obesity or overweight; however, weight loss can be challenging to achieve and maintain without bariatric surgery. Currently, no approved anti-obesity medication has demonstrated effectiveness in OSA management. This study is evaluating the efficacy and safety of tirzepatide for treatment of moderate to severe OSA in people with obesity. SURMOUNT-OSA, a randomized, placebo -controlled, 52-week phase 3 trial, is investigating the efficacy and safety of tirzepatide for treatment of moderate to severe OSA (apnea hypopnea- index ≥15 events/h) in participants with obesity (body mass index ≥30 kg/m2) and an established OSA diagnosis. SURMOUNT-OSA is made of 2 intervention-specific appendices (ISAs): ISA-1 includes participants with no current OSA treatment, and ISA-2 includes participants using positive airway pressure therapy. Overall, 469 participants have been random
Cohort, case-control, and cross-sectional human studies.
Comprehensive understanding of the treatment of insomnia with lemborexant.
Inoue Y, Koebis M · Expert review of clinical pharmacology · 2025
Benzodiazepine derivatives and Z-drugs have traditionally been the cornerstone of pharmacological insomnia treatment. However, concerns regarding increased risks of falls, next-morning residual effects, dose tolerance, dependence, and withdrawal symptoms have prompted growing interest in alternative therapies. This review critically assesses the effectiveness and challenges of lemborexant, a dual orexin receptor antagonist (DORA), in treating insomnia. It draws on current pharmacokinetic and clinical pharmacodynamic evidence, including data from phase 3 trials and meta-analyses. Lemborexant, with relative selectivity for the orexin receptor type 2, offers robust efficacy for both sleep initiation and maintenance. Its pharmacokinetic profile yields a quick onset and steep decline in plasma levels, helping minimize next-morning residual effects despite a long terminal half-life. Network meta-analyses demonstrate improvements in subjective and objective sleep measures, with lemborexant
Roles of vitamins and nutrition in obstructive sleep apnea.
Archontogeorgis K, Nena E, Steiropoulos P · Expert review of respiratory medicine · 2025
Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder, with a prevalence that rises alongside with the increasing prevalence of obesity. OSA is characterized by a low-inflammatory state and is followed by cardiovascular and metabolic sequelae. Continuous positive airway pressure (CPAP) represents the cornerstone of treatment for severe OSA. However, poor compliance with CPAP treatment renders OSA treatment a challenging venture. Weight loss and exercise are recommended as adjunctive treatment options for OSA. Several diets have proven to facilitate weight loss, and to alleviate the inflammatory status in patients with OSA. Moreover, several vitamins exhibit antioxidant properties that beneficially affect OSA pathology and reduce the risk of cardiovascular complications. This narrative review aims to summarize the current knowledge regarding the effect of nutrition and vitamin deficiencies on OSA. Included were publications, relevant to the topic, with diffe
The Association Between Dietary Vitamin C and Sleep Disorders: A Cohort Study Based on UK Biobank.
Zhang Q, Qi X, Wang Z, Zhang D, Wang T · Nutrients · 2024 · n=221
Objective: Approximately 30% of adults globally suffer from sleep disorders. However, there are few longitudinal studies on the association between dietary vitamin C and sleep disorders. This study aimed to investigate the association between dietary vitamin C intake and various types of sleep disorders, including sleep apnea and insomnia. Methods: We enrolled 68,221 participants from the UK Biobank. Dietary vitamin C intake was assessed using a 24 h dietary recall questionnaire. We employed a Cox regression model to assess the association between dietary vitamin C and sleep disorders and used restricted cubic spline models to investigate potential nonlinear relationships. Stratified and sensitivity analyses were also conducted to validate the findings. Results: The results indicated that vitamin C intake at the Q4 level (132.88-191.51 mg/d) was significantly associated with a reduced risk of sleep disorders, with an HR (95% CI) of 0.78 (0.65-0.94), and against sleep apnea, with an HR
Public-health agencies: NCCIH, NIH, CDC, NHS.
NCCIH
The NCCIH provides in-depth information about complementary and integrative health approaches for sleep disorders, including considerations for conditions like sleep apnea.
National Heart, Lung, and Blood Institute (NHLBI) / NIH
This page provides comprehensive health information on sleep apnea, covering causes, risk factors, symptoms, diagnosis, and treatment options for the general public.
National Health Service (NHS)
The NHS provides official health guidance for the public on sleep apnoea, outlining symptoms, causes, diagnosis, and available treatments within the UK healthcare system.
Registered ongoing or completed trials (ClinicalTrials.gov).
n=50 · NCT02485236 · COMPLETED · COMPLETED
The study aims to compare the efficacy of Nasal High Flow Therapy (NHF) with low-flow oxygen supplementation in improving postoperative intermittent desaturations. If so, this mode of therapy would provide a cost effective, relatively easy to implement, and better tolerated treatment to Continuous Positive Airway Pressure (CPAP) for oxygen stabilization.
n=20 · NCT01441622 · COMPLETED · COMPLETED
Continuous Positive Airway Pressure (CPAP) is the standard treatment in patients with Obstructive Sleep Apnea Syndrome (OSAS). The goal of the study is to evaluate CPAP treatment duration recorded by the AL539 during attended in-hospital polysomnography in patients with Obstructive Sleep Apnea Syndrome.
n=44 · NCT00665977 · COMPLETED · COMPLETED
1. CPAP compliance will be significantly higher in both the heated humidity with Thermosmart™ and the nasal steroid phases compared to the double placebo phase. 2. CPAP compliance will be comparably improved in the heated humidity with Thermosmart™ phase versus the nasal steroid phase. 3. Improvement in nasal symptoms in using CPAP will be significantly improved in both the heated humidity with Thermosmart™ and the nasal steroid phases compared to the double placebo phase, and comparable between the heated humidity with Thermosmart™ phase versus the nasal steroid phase. 4. Secondary to improvements in CPAP compliance, measures of daytime functioning and quality of life will improve in the heated humidity with Thermosmart™ versus double placebo.
Curated cross-source summaries (TRIP Database and similar).
TRIP Database
TRIP Database is a clinical search engine designed to allow health professionals to rapidly find answers to their clinical questions, including evidence related to sleep apnea.
Cochrane Library: Sleep apnoea
Cochrane
The Cochrane Library provides a collection of high-quality, independent evidence to inform healthcare decision-making, including systematic reviews related to sleep apnoea interventions and diagnostics.
TRIP Database
TRIP Database is a clinical search engine designed to allow users to quickly and easily find high-quality research evidence to support their practice, including numerous resources on sleep apnoea.
Conventional medical care for sleep apnea often includes Continuous Positive Airway Pressure (CPAP) therapy, oral appliances, and in some cases, surgery. It is crucial to consult with a healthcare provider for diagnosis and to discuss appropriate treatment options, as untreated sleep apnea can have serious health consequences.
Latest News
Health Videos
This information is for educational purposes only and should not be considered medical advice. Sleep apnea is a serious medical condition that requires professional diagnosis and treatment. Always consult with a qualified healthcare provider before making any decisions about your health or treatment
Found something that helped your sleep apnea?
Help others see what actually works.
Found something that helped your sleep apnea?
Real-world results help others choose what's worth trying.